Gene Expression Monitoring of Mononuclear Cells (MNC) Subpopulations and Immunological Status and Metabolome Defining of Healthy Population

This study has been completed.
Sponsor:
Information provided by:
Blood Transfusion Centre of Slovenia
ClinicalTrials.gov Identifier:
NCT01052649
First received: July 24, 2009
Last updated: January 19, 2010
Last verified: July 2009
  Purpose

Study on healthy volunteers is focusing on analysis of transcriptome profile fluctuations in healthy population in three mononuclear cell types (CD4+ cells, CD56+ cells and CD4+CD25+ cells)and should provide a reference for comparison with transcriptomic data of any disease state.Furthermore, metabolome and immunological status are defined on same samples.


Condition Intervention
Gene Expression
Metabolomics
Immunological Status
Other: Blood sampling

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Gene Expression Monitoring of Peripheral Blood Mononuclear Cells Subpopulations (CD4+ Cells, CD56+ Cells and CD4+CD25+ Cells) and Immunological Status and Metabolome Defining of Healthy Population

Further study details as provided by Blood Transfusion Centre of Slovenia:

Study Start Date: August 2008
Groups/Cohorts Assigned Interventions
Healthy volunteers Other: Blood sampling

  Eligibility

Ages Eligible for Study:   20 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

healthy population

Criteria

Inclusion Criteria:

  • age: 20-70 years
  • healthy

Exclusion Criteria:

  • acute or chronic diseases
  • pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01052649

Locations
Slovenia
Blood Transfusion Centre of Slovenia
Ljubljana, Slovenia, 1000
Sponsors and Collaborators
Blood Transfusion Centre of Slovenia
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01052649     History of Changes
Other Study ID Numbers: MNC -1-4
Study First Received: July 24, 2009
Last Updated: January 19, 2010
Health Authority: Slovenia: Ethics Committee

Keywords provided by Blood Transfusion Centre of Slovenia:
MNC subpopulations
Gene Expression
Metabolomics
Immunological Status

ClinicalTrials.gov processed this record on July 20, 2014